Phase I/II pilot study of gevokizumab [XOMA 052] in resistant uveitis of Behcet's disease
Latest Information Update: 21 Jul 2011
At a glance
- Drugs Gevokizumab (Primary)
- Indications Behcet's syndrome; Panuveitis; Posterior uveitis; Retinal vascular occlusion
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
Most Recent Events
- 21 Jul 2011 New trial record